Global and Japan RNAi Technologies Market 2021 by Company, Type and Application, Forecast to 2026
Global and Japan RNAi Technologies Market 2021 by Company, Type and Application, Forecast to 2026
The RNAi Technologies study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Market Overview
The global RNAi Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.6% in the forecast period of 2020 to 2025 and will expected to reach USD 363.3 million by 2025, from USD 303.9 million .
The RNAi Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
RNAi Technologies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, RNAi Technologies market has been segmented into Oncology, Ocular disorders, Respiratory disorders, Liver diseases, Other, etc.
Breakdown by Application, RNAi Technologies has been segmented into Research, Therapeutics, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global RNAi Technologies market presented in the report. This section sheds light on the sales growth of different regional and country-level RNAi Technologies markets. For the historical and forecast period 2016 to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global RNAi Technologies market.
For Japan, this report analyses the Japan market by players, Type and Application, For the period 2016-2026.
Competitive Landscape and RNAi Technologies Market Share Analysis
RNAi Technologies competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, RNAi Technologies revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2016-2021, this study provides the RNAi Technologies revenue and market share for each player covered in this report.
The major players covered in RNAi Technologies are: Alnylam Pharmaceuticals, Invitrogen, Ionis Pharmaceuticals, Benitec Biopharma Ltd, Qiagen, Filmtec Corporation, RXI Pharmaceuticals, Quark Pharmaceuticals Inc., Ambion, etc. Among other players domestic and global, RNAi Technologies market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
Alnylam Pharmaceuticals
Invitrogen
Ionis Pharmaceuticals
Benitec Biopharma Ltd
Qiagen
Filmtec Corporation
RXI Pharmaceuticals
Quark Pharmaceuticals Inc.
Ambion
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Type, covers:
Oncology
Ocular disorders
Respiratory disorders
Liver diseases
Other
Market segment by Application, can be divided into
Research
Therapeutics
1 Market Overview
1.1 Product Overview and Scope of RNAi Technologies
1.2 Classification of RNAi Technologies by Type
1.2.1 Overview: Global RNAi Technologies Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global RNAi Technologies Revenue Market Share by Type
1.2.3 Oncology
1.2.4 Ocular disorders
1.2.5 Respiratory disorders
1.2.6 Liver diseases
1.2.7 Other
1.3 Global RNAi Technologies Market by Application
1.3.1 Overview: Global RNAi Technologies Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Research
1.3.3 Therapeutics
1.4 Global RNAi Technologies Market Size and Forecast (2016-2026)
1.5 Global RNAi Technologies Market Size by Regions: 2019 Versus 2021 Versus 2026
1.6 Global RNAi Technologies Market Size by Regions (2016-2021)
1.7 Global RNAi Technologies Market Size and Forecast by Regions (2020-2025)
1.7.1 North America RNAi Technologies Status and Prospect (2016-2026)
1.7.2 Europe RNAi Technologies Status and Prospect (2016-2026)
1.7.3 Asia RNAi Technologies Status and Prospect (2016-2026)
1.7.4 South America RNAi Technologies Status and Prospect (2016-2026)
1.7.5 Middle East & Africa RNAi Technologies Status and Prospect (2016-2026)
2 Company Profiles
2.1 Alnylam Pharmaceuticals
2.1.1 Alnylam Pharmaceuticals Details
2.1.2 Alnylam Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Alnylam Pharmaceuticals SWOT Analysis
2.1.4 Alnylam Pharmaceuticals Product and Services
2.1.5 Alnylam Pharmaceuticals RNAi Technologies Revenue, Gross Margin and Market Share (2019-2020)
2.2 Invitrogen
2.2.1 Invitrogen Details
2.2.2 Invitrogen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Invitrogen SWOT Analysis
2.2.4 Invitrogen Product and Services
2.2.5 Invitrogen RNAi Technologies Revenue, Gross Margin and Market Share (2019-2020)
2.3 Ionis Pharmaceuticals
2.3.1 Ionis Pharmaceuticals Details
2.3.2 Ionis Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ionis Pharmaceuticals SWOT Analysis
2.3.4 Ionis Pharmaceuticals Product and Services
2.3.5 Ionis Pharmaceuticals RNAi Technologies Revenue, Gross Margin and Market Share (2019-2020)
2.4 Benitec Biopharma Ltd
2.4.1 Benitec Biopharma Ltd Details
2.4.2 Benitec Biopharma Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Benitec Biopharma Ltd SWOT Analysis
2.4.4 Benitec Biopharma Ltd Product and Services
2.4.5 Benitec Biopharma Ltd RNAi Technologies Revenue, Gross Margin and Market Share (2019-2020)
2.5 Qiagen
2.5.1 Qiagen Details
2.5.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Qiagen SWOT Analysis
2.5.4 Qiagen Product and Services
2.5.5 Qiagen RNAi Technologies Revenue, Gross Margin and Market Share (2019-2020)
2.6 Filmtec Corporation
2.6.1 Filmtec Corporation Details
2.6.2 Filmtec Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Filmtec Corporation SWOT Analysis
2.6.4 Filmtec Corporation Product and Services
2.6.5 Filmtec Corporation RNAi Technologies Revenue, Gross Margin and Market Share (2019-2020)
2.7 RXI Pharmaceuticals
2.7.1 RXI Pharmaceuticals Details
2.7.2 RXI Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 RXI Pharmaceuticals SWOT Analysis
2.7.4 RXI Pharmaceuticals Product and Services
2.7.5 RXI Pharmaceuticals RNAi Technologies Revenue, Gross Margin and Market Share (2019-2020)
2.8 Quark Pharmaceuticals Inc.
2.8.1 Quark Pharmaceuticals Inc. Details
2.8.2 Quark Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Quark Pharmaceuticals Inc. SWOT Analysis
2.8.4 Quark Pharmaceuticals Inc. Product and Services
2.8.5 Quark Pharmaceuticals Inc. RNAi Technologies Revenue, Gross Margin and Market Share (2019-2020)
2.9 Ambion
2.9.1 Ambion Details
2.9.2 Ambion Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Ambion SWOT Analysis
2.9.4 Ambion Product and Services
2.9.5 Ambion RNAi Technologies Revenue, Gross Margin and Market Share (2019-2020)
3 Market Competition, by Players
3.1 Global RNAi Technologies Market Size by Players (2016-2021)
3.2 Japan RNAi Technologies Market Size by Players (2016-2021)
3.3 Market Concentration Rate
3.3.1 Top 5 RNAi Technologies Players Market Share
3.3.2 Top 10 RNAi Technologies Players Market Share
4 North America Market Size and Forecast by Countries
4.1 North America RNAi Technologies Market Size by Countries (2016-2021)
4.2 North America RNAi Technologies Market Size and Forecast by Countries (2015-2026)
4.3 United States RNAi Technologies Market Size and Forecast (2016-2026)
4.4 Canada RNAi Technologies Market Size and Forecast (2016-2026)
4.5 Mexico RNAi Technologies Market Size and Forecast (2016-2026)
5 Europe Market Size and Forecast by Countries
5.1 Europe RNAi Technologies Market Size by Countries (2016-2021)
5.2 Europe RNAi Technologies Market Size and Forecast by Countries (2015-2026)
5.3 Germany RNAi Technologies Market Size and Forecast (2016-2026)
5.4 France RNAi Technologies Market Size and Forecast (2016-2026)
5.5 UK RNAi Technologies Market Size and Forecast (2016-2026)
5.6 Russia RNAi Technologies Market Size and Forecast (2016-2026)
5.7 Italy RNAi Technologies Market Size and Forecast (2016-2026)
6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific RNAi Technologies Market Size by Regions (2016-2021)
6.2 Asia-Pacific RNAi Technologies Market Size and Forecast by Regions (2015-2026)
6.3 China RNAi Technologies Market Size and Forecast (2016-2026)
6.4 Japan RNAi Technologies Market Size and Forecast (2016-2026)
6.5 Korea RNAi Technologies Market Size and Forecast (2016-2026)
6.6 India RNAi Technologies Market Size and Forecast (2016-2026)
6.7 Southeast Asia RNAi Technologies Market Size and Forecast (2016-2026)
7 South America Market Size and Forecast by Countries
7.1 South America RNAi Technologies Market Size by Countries (2016-2021)
7.2 South America RNAi Technologies Market Size and Forecast by Countries (2015-2026)
7.3 Brazil RNAi Technologies Market Size and Forecast (2016-2026)
7.4 Argentina RNAi Technologies Market Size and Forecast (2016-2026)
8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa RNAi Technologies Revenue by Regions (2016-2021)
8.2 Middle East & Africa RNAi Technologies Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia RNAi Technologies Market Size and Forecast (2016-2026)
8.4 UAE RNAi Technologies Market Size and Forecast (2016-2026)
8.5 Egypt RNAi Technologies Market Size and Forecast (2016-2026)
8.6 South Africa RNAi Technologies Market Size and Forecast (2016-2026)
9 Market Size Segment by Type
9.1 Global RNAi Technologies Market Size and Forecast by Type (2016-2026)
9.1.1 Global RNAi Technologies Market Size by Type (2016-2021)
9.1.2 Global RNAi Technologies Market Size Forecast by Type (2020-2025)
9.2 Japan RNAi Technologies Market Size and Forecast by Type (2016-2026)
9.2.1 Japan RNAi Technologies Market Size by Type (2016-2021)
9.2.2 Japan RNAi Technologies Market Size Forecast by Type (2020-2025)
10 Market Size Segment by Application
10.1 Global RNAi Technologies Market Size and Forecast by Application (2016-2026)
10.1.1 Global RNAi Technologies Market Size by Application (2016-2021)
10.1.2 Global RNAi Technologies Market Size Forecast by Application (2020-2025)
10.2 Japan RNAi Technologies Market Size and Forecast by Application (2016-2026)
10.2.1 Japan RNAi Technologies Market Size by Application (2016-2021)
10.2.2 Japan RNAi Technologies Market Size Forecast by Application (2020-2025)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US
Research Methodology:
RNAi Technologies Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|